Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teva Pharmaceutical (DE:TEV)
FRANKFURT:TEV
Holding DE:TEV?
Track your performance easily
See the Price Targets and Ratings of:
TEV Analyst Ratings
Strong Buy
5 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TEV Stock 12 Month Forecast
Average Price Target
€21.60
▲(32.92% Upside)
| Highest Price Target€24.42 | Average Price Target€21.60 | Lowest Price Target€16.90 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
Reiterated
11/11/24
Bank of America Securities
Reiterated
11/06/24
J.P. Morgan
Reiterated
10/21/24
Jefferies
Reiterated
09/23/24
Piper Sandler
Reiterated
08/28/24
Evercore ISI
―
Buy
―
Assigned
08/02/24
Evercore ISI Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)
Argus Research
―
Buy
―
Reiterated
08/01/24
Argus Research Reaffirms Their Buy Rating on Teva Pharmaceutical (TEVA)
Goldman Sachs
€10.33→€15.03
Hold
-7.53%
Downside
Reiterated
05/10/24
Teva Pharma (TEVA) PT Raised to $16 at Goldman SachsGoldman Sachs analyst Nathan Rich raised the price target on Teva Pharma (NYSE: TEVA) to $16.00 (from $11.00) while maintaining a Neutral rating.
HSBC
€12.21
Buy
-24.87%
Downside
Initiated
12/18/23
Teva initiated with a Buy at HSBCTeva initiated with a Buy at HSBC
Best Analysts Covering Teva Pharmaceutical
Which Analyst Should I Follow If I Want to Buy DE:TEV and Sell After:
1 Month
xxx
Success Rate
12/22 ratings generated profit
Average Return
+1.77%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 54.55% of your transactions generating a profit, with an average return of +1.77% per trade.
3 Months
xxx
Success Rate
11/22 ratings generated profit
Average Return
+3.11%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +3.11% per trade.
1 Year
Success Rate
13/22 ratings generated profit
Average Return
+24.95%
reiterated a buy rating 12 days ago
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 59.09% of your transactions generating a profit, with an average return of +24.95% per trade.
2 Years
xxx
Success Rate
14/22 ratings generated profit
Average Return
+32.99%
reiterated a xxx
rating 12 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 63.64% of your transactions generating a profit, with an average return of +32.99% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TEV Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
0
0
0
0
0
Buy
18
17
18
15
13
Hold
5
2
2
2
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
19
20
17
14
Each month's total comprises the sum of three months' worth of ratings.
TEV Financial Forecast
TEV Stock Forecast FAQ
What is DE:TEV’s average 12-month price target, according to analysts?
Based on analyst ratings, Teva Pharmaceutical’s 12-month average price target is €21.60.
What is DE:TEV’s upside potential, based on the analysts’ average price target?
Teva Pharmaceutical has 32.92% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Teva Pharmaceutical a Buy, Sell or Hold?
Teva Pharmaceutical has a consensus rating of Strong Buy, which is based on 5 buy ratings, 1 hold ratings and 0 sell ratings.
What is Teva Pharmaceutical’s share price target?
The average share price target for Teva Pharmaceutical is €21.60. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €24.42 ,and the lowest forecast is €16.90. The average share price target represents 32.92% Increase from the current price of €16.25.
The highest analyst share price target is €24.42 ,and the lowest forecast is €16.90. The average share price target represents 32.92% Increase from the current price of €16.25.
What do analysts say about Teva Pharmaceutical?
Teva Pharmaceutical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of Teva Pharmaceutical?
To buy shares of DE:TEV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.